|Table of Contents|

Research progress of pyroptosis and mechanism in tumor radiotherapy

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 02
Page:
351-355
Research Field:
Publishing date:

Info

Title:
Research progress of pyroptosis and mechanism in tumor radiotherapy
Author(s):
LI Dongdong1WANG Chengzhi1ZHANG Xiaoqing2LIU Peimin1
1.The Second Affiliated Hospital of Henan University of Chinese Medicine,Henan Zhengzhou 450002,China;2.The First Affiliated Hospital of Zhengzhou University,Henan Zhengzhou 450052,China.
Keywords:
pyroptosismalignant tumorradiotherapyresearch progress
PACS:
R730.55
DOI:
10.3969/j.issn.1672-4992.2024.02.028
Abstract:
Pyroptosis is a new type of cell death,which has bidirectionally modulatory effect in tumor.On the one hand,pyroptosis promotes cancer cell death,inhibit tumor cell proliferation,enhance radiochemotherapy sensitivity,and improve anti-tumor immunity.On the other hand,radiation therapy is an important means of malignant tumor treatment,pyroptosis induces radiation inflammatory damage and affects the efficacy of radiotherapy,however,the potential mechanism of pyroptosis in radiotherapy has not been fully clarified.This article summarizes the mechanism of pyroptosis in anti-tumor therapy and the dual role of pyroptosis in radiotherapy,and looks forward to the application and dilemma of pyroptosis in radiotherapy,discusses the feasibility of targeting pyroptosis to improve radiotherapy efficacy and reduce radiation damage,hoping to provide a reference for the follow-up mechanism research of radiotherapy,and provide a new direction for the research of radiotherapy targeting pyroptosis.

References:

[1] YU P,ZHANG X,LIU N,et al.Pyroptosis:mechanisms and diseases[J].Signal Transduction and Targeted Therapy,2021,6(1):128.
[2] DI MP,MIAO JJ,PAN QZ,et al.OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis[J].Journal of Experimental & Clinical Cancer Research,2022,160:125101.
[3] YANG JQ,GUO W,HUANG R,et al.Letter to the editor regarding "STAT3β disrupted mitochondrial electron transport chain enhances chemosensitivity by inducing pyroptosis in esophageal squamous cell carcinoma”[J].Cancer Letters,2022,534:215584.
[4] XIAO Y,ZHANG T,MA XB,et al.Microenvironment-responsive prodrug-induced pyroptosis boosts cancer immunotherapy[J].Advanced Science,2021,8(24):e2101840.
[5] HANANIA AN,MAINWARING W,GHEBRE Y,et al.Radiation-induced lung injury:assessment and management[J].Chest,2019,156(1):150-162.
[6] LEE C,DO HTT,HER J,et al.Inflammasome as a promising therapeutic target for cancer[J].Life Sciences,2019,231:116593.
[7] LIU X,ZHANG ZB,RUAN JB,et al.Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores[J].Nature,2016,535:153-158.
[8] SHI XL,YANG YW,ZHANG W,et al.FLASH X-ray spares intestinal crypts from pyroptosis initiated by cGAS-STING activation upon radioimmunotherapy[J].Proceedings of the National Academy of Sciences of the United States of America,2022,131:105398.
[9] WU QZ,GUO JX,LIU YN,et al.YAP drives fate conversion and chemoresistance of small cell lung cancer[J].Science Advances,2021,7(40):eabg1850.
[10] ZHANG ZB,ZHANG Y,JUDY L.Lighting a fire:can we harness pyroptosis to ignite antitumor immunity[J].Cancer Immunology Research,2021,9(1):2-7.
[11] ZHAO QW,FENG HR,YANG ZY,et al.The central role of a two-way positive feedback pathway in molecular targeted therapies-mediated pyroptosis in anaplastic thyroid cancer[J].Clinical and Translational Medicine,2022,12(2):e727.
[12] DING J,WANG K,LIU W,et al.Pore-forming activity and structural autoinhibition of the gasdermin family[J].Nature,2016,535(7610):111-116.
[13] WANG YP,GAO WQ,SHI XY,et al.Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin[J].Nature,2017,547:99-103.
[14] SHI J,ZHAO Y,WANG K,et al.Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J].Nature,2015,526(7575):660-665.
[15] DAVIS MA,FAIRGRIEVE MR,DH ANDREAS,et al.Calpain drives pyroptotic vimentin cleavage,intermediate filament loss,and cell rupture that mediates immunostimulation[J].Proceedings of the National Academy of Sciences of the United States of America,2019,116(11):5061-5070.
[16] PLACE DE,KANNEGANTI TD.The innate immune system and cell death in autoinflammatory and autoimmune disease[J].Current Opinion in Immunology,2020,67:95-105.
[17] ESKANDARI EBRAHIM,EAVES CONNIE J.Paradoxical roles of caspase-3 in regulating cell survival,proliferation,and tumorigenesis[J].The Journal of Cell Biology,2022,221(6):1295-1310.
[18] ZHOU CK,LI CM,ZHENG YH,et al.Identification of pyroptosis-related signature for cervical cancer predicting prognosis[J].Aging,2021,13(22):24795-24814.
[19] LI LJ,WANG SM,ZHOU WH,et al.Balance cell apoptosis and pyroptosis of caspase-3-activating chemotherapy for better antitumor therapy[J].Cancers (Basel),2022,15(1):1-25.
[20] ZHOU ZW,ZHOU ZW,HE HB,et al.Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells[J].Science (New York,N.Y.),2020,368(6494):961-963.
[21] LU HJ,ZHANG SZ,WU J,et al.Molecular targeted therapies elicit concurrent apoptotic and GSDME-dependent pyroptotic tumor cell death[J].Clin Cancer Res,2018,24:6066-6077.
[22] CUI J,ZHOU Z,YANG H,et al.MST1 suppresses pancreatic cancer progression via ROS-induced pyroptosis[J].Mol Cancer Res,2019,17(6):1316-1325.
[23] 任彩佩,张一楠,吴亚俐,等.白藜芦醇抑制肠癌细胞焦亡的作用[J].中国应用生理学杂志,2022,38(04):326-332. REN CP,ZHANG YN,WU YL,et al.Effects of resveratrol on inhibiting pyroptosis of intestinal cancer cells[J].Chinese Journal of Applied Physiology,2022,38(04):326-332.
[24] TONG WJ,GUO JH,YANG CF.Tanshinone II A enhances pyroptosis and represses cell proliferation of HeLa cells by regulating miR-145/GSDMD signaling pathway[J].Bioscience Reports,2020,40(4):159-162.
[25] VASAN NEIL,BASELGA JOSE,HYMAN DAVID M,et al.A view on drug resistance in cancer[J].Nature,2019,575(7782):299-309.
[26] ROMANI ANDREA MP.Cisplatin in cancer treatment[J].Biochemical Pharmacology,2022,20(6):453-561.
[27] LI RY,ZHENG ZY,ZHEN Y,et al.Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer[J].Chemico-Biological Interactions,2022,361(1):343-351.
[28] WU MJ,WANG Y,YANG D,et al.A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma[J].EBioMedicine,2019,41:244-255.
[29] ZHENG ZY,YANG PL,LI RY,et al.STAT3β disrupted mitochondrial electron transport chain enhances chemosensitivity by inducing pyroptosis in esophageal squamous cell carcinoma[J].Cancer Letters,2021,522:171-183.
[30] CHEN J,GE LL,SHI XY,et al.Lobaplatin induces pyroptosis in cervical cancer cells via the Caspase-3/GSDME pathway[J].Anti-cancer Agents in Medicinal Chemistry,2022,402:461-474.
[31] CHEN ZD,XU G,WU D,et al.Lobaplatin induces pyroptosis through regulating cIAP1/2,ripoptosome and ROS in nasopharyngeal carcinoma[J].Biochemical Pharmacology,2020,177:114023.
[32] TAO HY,HE F,SHI QY,et al.Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma:Experiences of two centers[J].Cancer Med,2023,12(6):6811-6824.
[33] GAO WT,WANG XY,ZHOU Y,et al.Autophagy,ferroptosis,pyroptosis,and necroptosis in tumor immunotherapy[J].Signal Transduction and Targeted Therapy,2022,245:104235.
[34] NIU X,CHEN LJ,LI Y,et al.Ferroptosis,necroptosis,and pyroptosis in the tumor microenvironment:Perspectives for immunotherapy of SCLC[J].Seminars in Cancer Biology,2022,321(3366):521-527.
[35] HU Y,CHEN D,HONG MJ,et al.Apoptosis,pyroptosis,and ferroptosis conspiringly induce immunosuppressive hepatocellular carcinoma microenvironment and γδ T-cell imbalance[J].Front Immunol,2022,13:845974.
[36] ZHANG RX,KANG R,TANG DL.The STING1 network regulates autophagy and cell death[J].Signal Transduction and Targeted Therapy,2021,6(1):248-259.
[37] WANG Q,WANG Y,DING J,et al.A bioorthogonal system reveals antitumour immune function of pyroptosis[J].Nature,2020,579(7799):421-426.
[38] CHEN HR,HAN ZY,LUO Q,et al.Radiotherapy modulates tumor cell fate decisions:a review[J].Radiat Oncol,2022,17:196.
[39] LI J,SUN J,LIU Z,et al.The roles of non-coding RNAs in radiotherapy of gastrointestinal carcinoma[J].Frontiers in Cell and Developmental Biology,2022,10:445624.
[40] CHENG H,CHEN LL,HUANG MC,et al.Hunting down NLRP3 inflammasome:An executioner of radiation-induced injury[J].Front Immunol,2022,13:967989.
[41] LI SQ,AN W,WANG B,et al.Inorganic nitrate alleviates irradiation-induced salivary gland damage by inhibiting pyroptosis[J].Free Radical Biology & Medicine,2021,104:645371.
[42] HERRERA FG,RONET C,DE OLZA MO,et al.Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy[J].Cancer Discovery,2021,12(1):108-133.
[43] TAN G,LIN CJ,HUANG CY,et al.Radiosensitivity of colorectal cancer and radiation-induced gut damages are regulated by gasdermin E[J].Cancer Letters,2021,529:1-10.
[44] CHEN HX,REN NX,YANG J,et al.Associations of genetic variations in pyroptosis related genes with acute adverse events in postoperative rectal cancer patients receiving concurrent chemoradiotherapy[J].Chin J Oncol,2023,45:146-152.
[45] 唐正.PP2A作为APE1/DNA-PKcs/hnRNPA1调控轴的限速酶在端粒保护中的调控机制及临床价值[D].重庆:重庆大学,2021. TANG Z.The regulatory mechanism of PP2A as the key rate-limiting enzyme of the APE1/DNA-PKcs/hnRNPA1 regulatory axis in telomere protection and its clinical value[D].Chongqing:Chongqing University,2021.
[46] ZHANG T,WU DM,LUO PW,et al.CircNEIL3 mediates pyroptosis to influence lung adenocarcinoma radiotherapy by upregulating PIF1 through miR-1184 inhibition[J].Cell Death Dis,2022,13:167.
[47] LIU YG,CHEN JK,ZHANG ZT,et al.NLRP3 inflammasome activation mediates radiation-induced pyroptosis in bone marrow-derived macrophages[J].Cell Death & Disease,2017,8(2):e2579.
[48] LARIONOVA IRINA,RAKINA MILITSA,IVANYUK ELENA,et al.Radiotherapy resistance:identifying universal biomarkers for various human cancers[J].Journal of Cancer Research and Clinical Oncology,2022,148(5):1015-1031.
[49] 宋永浩,夏炎春,周诚忠,等.调强适形放疗致老年食管癌放射性肺损伤的相关因素分析[J].现代肿瘤医学,2017,25(02):224-226. SONG YH,XIA YC,ZHOU CZ,et al.Analysis of factors of radiation-induced lung injury with IMRT for elderly esophageal carcinoma patients[J].Modern Oncology,2017,25(02):224-226.
[50] 唐斯晗.细胞焦亡与放射性肺损伤关系的初步探索[D].广州:广州医科大学,2021. TANG SH.A preliminary study on the relationship between pyroptosis and radiation-induced lung injury[D].Guangzhou:Guangzhou Medical University,2021.
[51] 李园.Connexin26调控辐射诱导皮肤免疫趋化因子CCL27的作用机理研究[D].合肥:安徽医科大学,2021. LI Y.The mechanism of Connexin26 in regulating radiation-induced changes of skin immunochemokine CCL27[D].Hefei:Anhui Medical University,2021.
[52] SMITH ALHAJI OSMAN,JU W.Gamma radiation induce inflammasome signaling and pyroptosis in microvascular endothelial cells[J].Journal of Inflammation Research,2021,14:3277-3288.
[53] WU T,LIU W,FAN T,et al.5-androstenediolprevents radiation injury in mice by promoting NF-kappaB signaling and inhibiting AIM2 inflammasome activation[J].Biomed Pharmacother,2020,121:109597.
[54] HE YZ,CAI YX,LIU JS,et al.Systematic analysis of a pyroptosis-related signature to predict the prognosis and immune microenvironment of lower-grade glioma[J].Cells,2022,11(24):3980-3987.

Memo

Memo:
National Natural Science Foundation of China(No.82204981);国家自然科学基金(编号:82204981);国家中医临床研究基地科研专项(编号:2021JDZX2002);河南省特色骨干学科中医学学科建设项目(编号:STG-ZYX06-202145);河南中医药大学博士科研基金项目(编号:2022BSJJ08)
Last Update: 1900-01-01